Latest News & Updates

Breaking News

  • 1 day ago

  • Vaibhavi M.

Cognition Therapeutics Secures FDA Alignment on Pivotal Zervimesine Trial Design for DLB Psychosis
Breaking News
Biocon Secures Malaysia MoH Insulin Supply Contracts Worth Over Rs. 515 Crore with Duopharma Biotech

Simantini Singh Deo

Other trending news you may like to read

Cognition Therapeutics Secures FDA Alignment on Pivotal Zervimesine Trial Design for DLB Psychosis

Cognition Therapeutics gains FDA alignment on zervimesine Phase 3 design for DLB psychosis, with NPI as a novel primary endpoint and a mid-2027 program start.

Vaibhavi M.

Pharma Now

Biocon Secures Malaysia MoH Insulin Supply Contracts Worth Over Rs. 515 Crore with Duopharma Biotech

Biocon wins Malaysia MoH insulin supply contracts worth over Rs. 515 crore, covering human insulin, glargine, and aspart via Duopharma Biotech.

Simantini Singh Deo

Pharma Now

Sun Pharma amongst 2026 S&P Dow Jones Best-in-Class World Index

Sun Pharma joins the 2026 S&P Dow Jones Best-in-Class World Index, one of 317 global companies and 25 from India recognised for industry-leading sustainability performance.

Mrudula Kulkarni

Pharma Now

FDA Finalizes Digital Health Technology Guidance Reshaping Remote Data Acquisition in Clinical Trials

FDA's final DHT guidance sets binding expectations for remote data acquisition in clinical trials, affecting protocol design and submission strategy.

Simantini Singh Deo

Pharma Now